• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞/肿瘤融合细胞疫苗诱导 CD4 T 细胞对肿瘤的消退作用。

Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccines.

机构信息

Department of Internal Medicine, The Jikei University School of Medicine, Chiba, Japan

Department of Urology, Mitsui Memorial Hospital, Tokyo, Japan.

出版信息

Anticancer Res. 2014 Aug;34(8):3917-24.

PMID:25075013
Abstract

BACKGROUND/AIM: Vaccination with fusions of dendritic cells (DCs) and mucin-1 (MUC1)-positive tumor cells (FC/MUC1) induces MUC1-specific antitumor immunity. However, little is known about the function of Cluster of Differentiation (CD)4 T-cells primed with FC/MUC1 in MUC1 transgenic (MUC1.Tg) mice.

MATERIALS AND METHODS

CD4 T-cells primed with FC/MUC1 were analyzed by flow cytometry. Antitumor immunity by adoptive transfer of primed CD4 T-cells in Rag2(-/-) mice was assessed.

RESULTS

The effector and memory T-cells generated with FC/MUC1 were crucial to maintenance of long-term antitumor immunity. MUC1-8-mer peptide SAPDTRPA presented by FC/MUC1 was recognized by CD4 and CD8 T-cells. A subset of primed CD4 T-cells possessed cytotoxicity to lyse major histocompatibility complex (MHC) class I and MUC1 positive tumor cells. Interestingly, adoptive transfer of primed CD4 T-cells prevented lung metastasis in Rag2(-/-) mice.

CONCLUSION

CD4 T-cells primed by FC/MUC1 play direct role in antitumor immunity.

摘要

背景/目的:用树突状细胞(DC)和黏蛋白-1(MUC1)阳性肿瘤细胞融合物(FC/MUC1)进行疫苗接种可诱导 MUC1 特异性抗肿瘤免疫。然而,对于用 FC/MUC1 刺激的 CD4 T 细胞在 MUC1 转基因(MUC1.Tg)小鼠中的功能知之甚少。

材料和方法

通过流式细胞术分析用 FC/MUC1 刺激的 CD4 T 细胞。通过在 Rag2(-/-)小鼠中过继转移刺激的 CD4 T 细胞来评估抗肿瘤免疫。

结果

用 FC/MUC1 产生的效应和记忆 T 细胞对于维持长期抗肿瘤免疫至关重要。由 FC/MUC1 呈递的 MUC1-8 肽 SAPDTRPA 被 CD4 和 CD8 T 细胞识别。刺激的 CD4 T 细胞的一个亚群具有细胞毒性,可裂解主要组织相容性复合物(MHC)I 类和 MUC1 阳性肿瘤细胞。有趣的是,过继转移刺激的 CD4 T 细胞可预防 Rag2(-/-)小鼠的肺转移。

结论

用 FC/MUC1 刺激的 CD4 T 细胞在抗肿瘤免疫中发挥直接作用。

相似文献

1
Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccines.树突状细胞/肿瘤融合细胞疫苗诱导 CD4 T 细胞对肿瘤的消退作用。
Anticancer Res. 2014 Aug;34(8):3917-24.
2
Vaccination with allogeneic dendritic cells fused to carcinoma cells induces antitumor immunity in MUC1 transgenic mice.用与癌细胞融合的同种异体树突状细胞进行疫苗接种可在MUC1转基因小鼠中诱导抗肿瘤免疫。
Clin Immunol. 2001 Nov;101(2):192-200. doi: 10.1006/clim.2001.5112.
3
Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.通过将缺乏MHC II类分子的树突状细胞与肿瘤细胞融合诱导抗肿瘤免疫受损。
J Immunol. 2005 Feb 1;174(3):1274-80. doi: 10.4049/jimmunol.174.3.1274.
4
The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic/tumor fusion cells in MUC1-transgenic mice.树突状细胞/肿瘤融合细胞在MUC1转基因小鼠体内对CD4和CD8 T细胞进行体内启动的动力学研究。
J Immunol. 2002 Mar 1;168(5):2111-7. doi: 10.4049/jimmunol.168.5.2111.
5
Selection and characterization of MUC1-specific CD8+ T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells.从用树突状细胞 - 癌细胞融合细胞免疫的MUC1转基因小鼠中筛选并鉴定MUC1特异性CD8 + T细胞。
Immunology. 2000 Nov;101(3):316-24. doi: 10.1046/j.1365-2567.2000.00101.x.
6
Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.通过树突状细胞-肿瘤融合疫苗免疫激发针对低免疫原性肿瘤的T细胞免疫。
J Immunol. 1998 Nov 15;161(10):5516-24.
7
CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice.CD4 + 淋巴细胞在体内提供MUC1特异性肿瘤免疫,这在体外无法检测到,且在MUC1转基因小鼠中不存在。
J Immunol. 1998 Nov 15;161(10):5500-6.
8
Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection.三种基于含有七个串联重复肿瘤特异性表位的140个氨基酸的MUC1肽的不同疫苗,在具有不同肿瘤排斥潜力的野生型与MUC1转基因小鼠中引发了不同的免疫效应机制。
J Immunol. 2001 Jun 1;166(11):6555-63. doi: 10.4049/jimmunol.166.11.6555.
9
Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity.热休克融合蛋白可诱导特异性和非特异性抗肿瘤免疫。
Eur J Immunol. 2006 May;36(5):1324-36. doi: 10.1002/eji.200535490.
10
Characterization of structure and direct antigen presentation by dendritic/tumor-fused cells as cancer vaccines.树突状/肿瘤融合细胞作为癌症疫苗的结构和直接抗原呈递特性。
Anticancer Res. 2013 Feb;33(2):347-54.

引用本文的文献

1
Tumor Hybrid Cells: Nature and Biological Significance.肿瘤杂交细胞:性质与生物学意义
Front Cell Dev Biol. 2022 Feb 15;10:814714. doi: 10.3389/fcell.2022.814714. eCollection 2022.
2
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting.抗癌疫苗接种中的树突状细胞:体外负载或体内靶向的原理
Cancers (Basel). 2020 Mar 5;12(3):590. doi: 10.3390/cancers12030590.
3
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer.乳腺癌中肿瘤微环境与免疫检查点之间的复杂相互作用
Cancers (Basel). 2019 Aug 19;11(8):1205. doi: 10.3390/cancers11081205.
4
Tumor Microenvironment and Cell Fusion.肿瘤微环境与细胞融合。
Biomed Res Int. 2019 Jul 11;2019:5013592. doi: 10.1155/2019/5013592. eCollection 2019.
5
Dendritic Cell Therapies for Hematologic Malignancies.用于血液系统恶性肿瘤的树突状细胞疗法
Mol Ther Methods Clin Dev. 2017 Mar 18;5:66-75. doi: 10.1016/j.omtm.2017.03.004. eCollection 2017 Jun 16.
6
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines.基于树突状细胞-肿瘤融合细胞的癌症疫苗
Int J Mol Sci. 2016 May 26;17(6):828. doi: 10.3390/ijms17060828.
7
MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.由糖基化或非糖基化肽或肿瘤来源的MUC1组成的MUC1疫苗,可以规避免疫编辑以控制MUC1转基因小鼠的肿瘤生长。
PLoS One. 2016 Jan 20;11(1):e0145920. doi: 10.1371/journal.pone.0145920. eCollection 2016.
8
Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes.MUC1-8聚体肽-T2细胞-β2微球蛋白复合物对静止期肺腺癌CD8 + T细胞的扩增作用
Oncol Rep. 2016 Jan;35(1):33-42. doi: 10.3892/or.2015.4328. Epub 2015 Oct 13.
9
Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme.基于树突状细胞的多形性胶质母细胞瘤免疫治疗
Biomed Res Int. 2015;2015:717530. doi: 10.1155/2015/717530. Epub 2015 Jun 17.
10
In Vitro Administration of Gold Nanoparticles Functionalized with MUC-1 Protein Fragment Generates Anticancer Vaccine Response via Macrophage Activation and Polarization Mechanism.通过巨噬细胞激活和极化机制,用MUC-1蛋白片段功能化的金纳米颗粒的体外给药产生抗癌疫苗反应。
J Cancer. 2015 May 15;6(6):583-92. doi: 10.7150/jca.11567. eCollection 2015.